Mycobacterial	B:C0026912
Caseinolytic	O
Protease	I:C1336776
Gene	I:C1336776
Regulator	I:C1336776
ClgR	O

Mycobacterial	O
Caseinolytic	B:C1336776
Protease	I:C1336776
Gene	I:C1336776
Regulator	I:C1336776
ClgR	O

Mycobacterial	O
Caseinolytic	O
Protease	I:C1336776
Gene	I:C1336776
Regulator	I:C1336776
ClgR	B:C1336776

Is	O
a	O
Substrate	O
of	O
Caseinolytic	B:C0052605
Protease	I:C0052605

The	O
mycobacterial	B:C0026912
caseinolytic	O
protease	I:C0052605
ClpP1P2	O
is	O
a	O
degradative	O
protease	I:C0030940
that	O
recently	O
gained	O
interest	O
as	O
a	O
genetically	O
and	O
pharmacologically	O
validated	O
drug	O
target	O
for	O
tuberculosis	O
.	O

The	O
mycobacterial	O
caseinolytic	B:C0052605
protease	I:C0052605
ClpP1P2	O
is	O
a	O
degradative	O
protease	I:C0030940
that	O
recently	O
gained	O
interest	O
as	O
a	O
genetically	O
and	O
pharmacologically	O
validated	O
drug	O
target	O
for	O
tuberculosis	O
.	O

The	O
mycobacterial	O
caseinolytic	O
protease	I:C0052605
ClpP1P2	B:C0052605
is	O
a	O
degradative	O
protease	I:C0030940
that	O
recently	O
gained	O
interest	O
as	O
a	O
genetically	O
and	O
pharmacologically	O
validated	O
drug	O
target	O
for	O
tuberculosis	O
.	O

The	O
mycobacterial	O
caseinolytic	O
protease	I:C0052605
ClpP1P2	O
is	O
a	O
degradative	B:C0030940
protease	I:C0030940
that	O
recently	O
gained	O
interest	O
as	O
a	O
genetically	O
and	O
pharmacologically	O
validated	O
drug	O
target	O
for	O
tuberculosis	O
.	O

The	O
mycobacterial	O
caseinolytic	O
protease	I:C0052605
ClpP1P2	O
is	O
a	O
degradative	O
protease	I:C0030940
that	O
recently	O
gained	O
interest	O
as	O
a	O
genetically	O
and	O
pharmacologically	O
validated	O
drug	B:C0013227
target	O
for	O
tuberculosis	O
.	O

The	O
mycobacterial	O
caseinolytic	O
protease	I:C0052605
ClpP1P2	O
is	O
a	O
degradative	O
protease	I:C0030940
that	O
recently	O
gained	O
interest	O
as	O
a	O
genetically	O
and	O
pharmacologically	O
validated	O
drug	O
target	O
for	O
tuberculosis	B:C0041296
.	O

The	O
first	O
whole	O
-	O
cell	O
active	O
ClpP1P2	B:C0052605
inhibitor	O
,	O
the	O
human	O
proteasome	O
inhibitor	I:C1443643
bortezomib	O
,	O
is	O
currently	O
undergoing	O
lead	O
optimization	O
to	O
introduce	O
selectivity	O
for	O
the	O
bacterial	O
target	O
.	O

The	O
first	O
whole	O
-	O
cell	O
active	O
ClpP1P2	O
inhibitor	B:C0014432
,	O
the	O
human	O
proteasome	O
inhibitor	I:C1443643
bortezomib	O
,	O
is	O
currently	O
undergoing	O
lead	O
optimization	O
to	O
introduce	O
selectivity	O
for	O
the	O
bacterial	O
target	O
.	O

The	O
first	O
whole	O
-	O
cell	O
active	O
ClpP1P2	O
inhibitor	O
,	O
the	O
human	B:C0086418
proteasome	O
inhibitor	I:C1443643
bortezomib	O
,	O
is	O
currently	O
undergoing	O
lead	O
optimization	O
to	O
introduce	O
selectivity	O
for	O
the	O
bacterial	O
target	O
.	O

The	O
first	O
whole	O
-	O
cell	O
active	O
ClpP1P2	O
inhibitor	O
,	O
the	O
human	O
proteasome	B:C1443643
inhibitor	I:C1443643
bortezomib	O
,	O
is	O
currently	O
undergoing	O
lead	O
optimization	O
to	O
introduce	O
selectivity	O
for	O
the	O
bacterial	O
target	O
.	O

The	O
first	O
whole	O
-	O
cell	O
active	O
ClpP1P2	O
inhibitor	O
,	O
the	O
human	O
proteasome	O
inhibitor	I:C1443643
bortezomib	B:C1176309
,	O
is	O
currently	O
undergoing	O
lead	O
optimization	O
to	O
introduce	O
selectivity	O
for	O
the	O
bacterial	O
target	O
.	O

The	O
first	O
whole	O
-	O
cell	O
active	O
ClpP1P2	O
inhibitor	O
,	O
the	O
human	O
proteasome	O
inhibitor	I:C1443643
bortezomib	O
,	O
is	O
currently	O
undergoing	O
lead	O
optimization	O
to	O
introduce	O
selectivity	O
for	O
the	O
bacterial	B:C0004611
target	O
.	O

How	O
inhibition	B:C1524081
of	O
ClpP1P2	O
translates	O
into	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
is	O
little	O
understood	O
.	O

How	O
inhibition	O
of	O
ClpP1P2	B:C0052605
translates	O
into	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
is	O
little	O
understood	O
.	O

How	O
inhibition	O
of	O
ClpP1P2	O
translates	O
into	O
whole	O
-	O
cell	O
antimicrobial	B:C1149574
activity	I:C1149574
is	O
little	O
understood	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
the	O
caseinolytic	B:C1336776
protease	I:C1336776
gene	I:C1336776
regulator	I:C1336776
ClgR	O
is	O
an	O
activator	O
of	O
the	O
clpP1P2	O
genes	I:C1335528
and	O
also	O
suggested	O
that	O
this	O
transcription	O
factor	I:C0040648
may	O
be	O
a	O
substrate	O
of	O
the	O
protease	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
the	O
caseinolytic	O
protease	I:C1336776
gene	I:C1336776
regulator	I:C1336776
ClgR	B:C1336776
is	O
an	O
activator	O
of	O
the	O
clpP1P2	O
genes	I:C1335528
and	O
also	O
suggested	O
that	O
this	O
transcription	O
factor	I:C0040648
may	O
be	O
a	O
substrate	O
of	O
the	O
protease	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
the	O
caseinolytic	O
protease	I:C1336776
gene	I:C1336776
regulator	I:C1336776
ClgR	O
is	O
an	O
activator	O
of	O
the	O
clpP1P2	B:C1335528
genes	I:C1335528
and	O
also	O
suggested	O
that	O
this	O
transcription	O
factor	I:C0040648
may	O
be	O
a	O
substrate	O
of	O
the	O
protease	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
the	O
caseinolytic	O
protease	I:C1336776
gene	I:C1336776
regulator	I:C1336776
ClgR	O
is	O
an	O
activator	O
of	O
the	O
clpP1P2	O
genes	I:C1335528
and	O
also	O
suggested	O
that	O
this	O
transcription	B:C0040648
factor	I:C0040648
may	O
be	O
a	O
substrate	O
of	O
the	O
protease	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
the	O
caseinolytic	O
protease	I:C1336776
gene	I:C1336776
regulator	I:C1336776
ClgR	O
is	O
an	O
activator	O
of	O
the	O
clpP1P2	O
genes	I:C1335528
and	O
also	O
suggested	O
that	O
this	O
transcription	O
factor	I:C0040648
may	O
be	O
a	O
substrate	O
of	O
the	O
protease	B:C0030940
.	O

Here	O
,	O
we	O
employ	O
promoter	B:C0086860
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	B:C1176309
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	B:C0085957
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	B:C0040649
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	B:C1335528
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	B:C1336776
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	B:C0086860
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	B:C1524081
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	B:C0052605
increases	O
cellular	O
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	B:C0007634
ClgR	O
levels	O
.	O

Here	O
,	O
we	O
employ	O
promoter	O
activity	O
reporters	O
and	O
direct	O
mRNA	O
level	O
measurements	O
showing	O
that	O
bortezomib	O
treatment	O
of	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
increased	O
transcription	O
of	O
clpP1P2	O
and	O
other	O
ClgR	O
-	O
dependent	O
promoters	O
,	O
suggesting	O
that	O
inhibition	O
of	O
ClpP1P2	O
increases	O
cellular	O
ClgR	B:C1336776
levels	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	B:C0960938
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	B:C1336776
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	B:C1293131
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	B:C0936012
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	B:C1336776
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	B:C0052605
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	B:C1336776
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	B:C0030956
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	B:C0597304
degradation	I:C0597304
by	O
ClpP1P2	O
.	O

Then	O
,	O
we	O
carried	O
out	O
red	O
fluorescent	I:C0960938
protein	I:C0960938
-	O
ClgR	O
fusion	O
analyses	O
to	O
show	O
that	O
ClgR	O
is	O
indeed	O
a	O
substrate	O
of	O
ClpP1P2	O
and	O
to	O
identify	O
ClgR's	O
C-terminal	O
nonapeptide	I:C0030956
APVVSLAVA	I:C0030956
as	O
the	O
signal	O
sufficient	O
for	O
recognition	O
and	O
efficient	O
protein	O
degradation	I:C0597304
by	O
ClpP1P2	B:C0052605
.	O

Interestingly	O
,	O
accumulation	B:C4055506
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	B:C1336776
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	B:C0004587
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	B:C3537153
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	B:C1524081
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	B:C0052605
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	B:C0243102
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	B:C1176309
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	O
activity	I:C1149575
.	O

Interestingly	O
,	O
accumulation	O
of	O
ClgR	O
appears	O
to	O
be	O
toxic	O
for	O
bacilli	O
,	O
suggesting	O
a	O
mechanism	O
for	O
how	O
pharmacological	O
inhibition	O
of	O
ClpP1P2	O
protease	I:C0052605
activity	O
by	O
bortezomib	O
translates	O
into	O
whole	O
-	O
cell	O
antibacterial	B:C1149575
activity	I:C1149575
.	O

With	O
9	O
million	O
new	O
cases	O
and	O
more	O
than	O
1	O
million	O
deaths	B:C1306577
per	O
year	O
,	O
tuberculosis	O
,	O
caused	O
by	O
Mycobacterium	O
tuberculosis	I:C0026926
,	O
is	O
the	O
biggest	O
infectious	O
disease	I:C0009450
killer	O
globally	O
.	O

With	O
9	O
million	O
new	O
cases	O
and	O
more	O
than	O
1	O
million	O
deaths	O
per	O
year	O
,	O
tuberculosis	B:C0041296
,	O
caused	O
by	O
Mycobacterium	O
tuberculosis	I:C0026926
,	O
is	O
the	O
biggest	O
infectious	O
disease	I:C0009450
killer	O
globally	O
.	O

With	O
9	O
million	O
new	O
cases	O
and	O
more	O
than	O
1	O
million	O
deaths	O
per	O
year	O
,	O
tuberculosis	O
,	O
caused	O
by	O
Mycobacterium	B:C0026926
tuberculosis	I:C0026926
,	O
is	O
the	O
biggest	O
infectious	O
disease	I:C0009450
killer	O
globally	O
.	O

With	O
9	O
million	O
new	O
cases	O
and	O
more	O
than	O
1	O
million	O
deaths	O
per	O
year	O
,	O
tuberculosis	O
,	O
caused	O
by	O
Mycobacterium	O
tuberculosis	I:C0026926
,	O
is	O
the	O
biggest	O
infectious	B:C0009450
disease	I:C0009450
killer	O
globally	O
.	O

New	O
drugs	B:C0013227
for	O
the	O
treatment	O
of	O
the	O
drug	O
-	O
resistant	O
forms	O
of	O
the	O
disease	O
are	O
needed	O
.	O

New	O
drugs	O
for	O
the	O
treatment	O
of	O
the	O
drug	O
-	O
resistant	O
forms	O
of	O
the	O
disease	B:C0012634
are	O
needed	O
.	O

Recently	O
,	O
a	O
new	O
target	O
-	O
lead	O
couple	O
,	O
the	O
mycobacterial	B:C0026912
protease	O
ClpP1P2	O
and	O
the	O
human	O
anticancer	O
drug	I:C0003392
bortezomib	O
,	O
was	O
identified	O
.	O

Recently	O
,	O
a	O
new	O
target	O
-	O
lead	O
couple	O
,	O
the	O
mycobacterial	O
protease	B:C0030940
ClpP1P2	O
and	O
the	O
human	O
anticancer	O
drug	I:C0003392
bortezomib	O
,	O
was	O
identified	O
.	O

Recently	O
,	O
a	O
new	O
target	O
-	O
lead	O
couple	O
,	O
the	O
mycobacterial	O
protease	O
ClpP1P2	B:C0052605
and	O
the	O
human	O
anticancer	O
drug	I:C0003392
bortezomib	O
,	O
was	O
identified	O
.	O

Recently	O
,	O
a	O
new	O
target	O
-	O
lead	O
couple	O
,	O
the	O
mycobacterial	O
protease	O
ClpP1P2	O
and	O
the	O
human	B:C0086418
anticancer	O
drug	I:C0003392
bortezomib	O
,	O
was	O
identified	O
.	O

Recently	O
,	O
a	O
new	O
target	O
-	O
lead	O
couple	O
,	O
the	O
mycobacterial	O
protease	O
ClpP1P2	O
and	O
the	O
human	O
anticancer	B:C0003392
drug	I:C0003392
bortezomib	O
,	O
was	O
identified	O
.	O

Recently	O
,	O
a	O
new	O
target	O
-	O
lead	O
couple	O
,	O
the	O
mycobacterial	O
protease	O
ClpP1P2	O
and	O
the	O
human	O
anticancer	O
drug	I:C0003392
bortezomib	B:C1176309
,	O
was	O
identified	O
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	B:C1171362
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	B:C0052605
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	B:C2755857
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	B:C0033684
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	B:C0004611
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	B:C0597304
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	B:C0030940
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	B:C0033684
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	B:C1524081
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	B:C0052605
exerts	O
whole	O
-	O
cell	O
antimicrobial	O
activity	I:C1149574
.	O

However	O
,	O
we	O
know	O
little	O
about	O
how	O
expression	O
of	O
this	O
protease	O
is	O
regulated	O
,	O
which	O
proteins	O
in	O
the	O
bacterium	O
it	O
degrades	O
,	O
how	O
the	O
protease	O
recognizes	O
its	O
target	O
proteins	O
,	O
and	O
how	O
the	O
inhibition	O
of	O
ClpP1P2	O
exerts	O
whole	O
-	O
cell	O
antimicrobial	B:C1149574
activity	I:C1149574
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	B:C0052605
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	B:C2755857
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	B:C1171362
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	B:C0002518
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	B:C3537153
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	B:C0052605
inhibition	O
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	B:C1524081
causes	O
bacterial	O
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	B:C0004611
growth	O
inhibition	I:C2249823
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
ClpP1P2	O
protease	I:C0052605
regulates	O
its	O
own	O
expression	O
,	O
and	O
we	O
identified	O
a	O
new	O
substrate	O
and	O
a	O
new	O
substrate	O
recognition	O
sequence	I:C0002518
and	O
a	O
mechanism	O
for	O
how	O
ClpP1P2	O
inhibition	O
causes	O
bacterial	O
growth	B:C2249823
inhibition	I:C2249823
.	O

